clinical trial · NCT06717152
Efficacy and Safety of SJP-0132 Eye Drops in Chinese Patients With Dry Eye Disease
Senju Pharmaceutical Science & Technology (Beijing) Co., Ltd.·phase3·completed·n = 427
Dry EyeSJP-0132Placebo
brief summary
This study will evaluate the safety and efficacy of SJP-0132 in Chinese Patients with Dry Eye. Patients will be randomly assigned to receive either SJP-0132 or placebo.
started
Dec 30, 2024
primary completion
Jul 28, 2025
completion
Sep 1, 2025
last updated
Nov 26, 2025
official title
A Randomized, Double-masked, Parallel, Multicenter, Phase 3 Study to Evaluate the Efficacy and Safety of SJP-0132 Eye Drops Compared With Placebo in Chinese Patients With Dry Eye Disease
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol